Arcus Biosciences (RCUS)
Develops small-molecule and antibody therapies for cancer and inflammatory diseases.
$26.29
vs last close−0.58 (−2.16%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 97.08% | 123.62M shares | |
|---|---|---|---|
| 240 holders · as of Jun 30, 2026 | |||
| Insiders | 4.50% | 5.73M shares | |
| 14 holders · as of Aug 24, 2026 | |||
| Strategic holders | 0.07% | 87.5K shares | |
| 1 holder · as of Dec 17, 2024 | |||
| Adds to | 101.65% | ||
127.33M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 101.65%; nothing is left for Other.
13F, as of Jun 30, 2026
240 holders · 123.62M shares · 49 new positions · 135 increased · 65 reduced · 25 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Gilead Sciences, Inc. | 31.42M | 24.68% | 0 | Aug 3, 2026 |
| BlackRock, Inc. | 16.42M | 12.89% | +1.19M | Aug 7, 2026 |
| State Street Corp | 6.03M | 4.74% | +616.6K | Aug 7, 2026 |
| Wellington Management Group LLP | 5.90M | 4.63% | −194.1K | Aug 14, 2026 |
| Suvretta Capital Management, LLC | 4.78M | 3.75% | −254.6K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 4.48M | 3.51% | +203.5K | Aug 13, 2026 |
| FMR LLC | 4.05M | 3.18% | +2.88M | Aug 13, 2026 |
| Vanguard Capital Management LLC | 3.89M | 3.05% | +31.6K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Gilead Sciences, Inc. | 24.70% | 31.42M | 13D | Aug 7, 2026 |
| BlackRock, Inc. | 10.40% | 12.74M | 13G | Jan 8, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Alexander Azoyofficer: Chief Accounting Officer | Sale | 2,827 | $30.00 | 39,581 |
| Jul 10, 2026 | Juan C. Jaenofficer: President | Sale · 2 lots | 20,067 | $28.62 | 822,240 |
| Jul 9, 2026 | Juan C. Jaenofficer: President | Sale | 48,502 | $30.05 | 842,307 |
| Jun 24, 2026 | Juan C. Jaenofficer: President | Sale | 6,431 | $29.66 | 890,809 |
| Jun 23, 2026 | Juan C. Jaenofficer: President | Sale · 2 lots | 15,764 | $27.73 | 897,240 |
| Jun 22, 2026 | Juan C. Jaenofficer: President | Sale | 9,236 | $27.03 | 913,004 |
| Jun 1, 2026 | Alexander Azoyofficer: Chief Accounting Officer | Sale | 2,562 | $25.77 | 39,581 |
| May 11, 2026 | II Robert C. Goeltzofficer: Chief Financial Officer | Sale | 7,763 | $25.63 | 84,161 |
| Jan 5, 2026 | Juan C. Jaenofficer: President | Sale · 3 lots | 31,823 | $21.41 | 922,240 |
| Dec 31, 2025 | II Robert C. Goeltzofficer: Chief Financial Officer | Sale | 6,552 | $23.38 | 67,924 |
House and Senate disclosures
Not reported.